Back to Search
Start Over
Impact of Novel Targeted Therapies and Cytogenetic Risk Groups on Outcome After Allogeneic Transplantation for Adult ALL
- Source :
- Transplantation and Cellular Therapy; February 2021, Vol. 27 Issue: 2 p165.e1-165.e11, 14861p
- Publication Year :
- 2021
-
Abstract
- •CD20+, Ph-like, and therapy-related ALL are novel high-risk subgroups in adults.•Allogeneic transplantation offsets the poor prognosis associated with these subgroups.•Targeted immunotherapies do not seem to independently predict for post-transplant outcomes.•Maintenance strategies are needed to reduce relapse post-transplant.
Details
- Language :
- English
- ISSN :
- 26666375 and 26666367
- Volume :
- 27
- Issue :
- 2
- Database :
- Supplemental Index
- Journal :
- Transplantation and Cellular Therapy
- Publication Type :
- Periodical
- Accession number :
- ejs55204495
- Full Text :
- https://doi.org/10.1016/j.jtct.2020.10.015